Urine tests cost Colorado Medicaid $1M per month in 2016

Colorado’s Medicaid program spent more than $1 million a month last year on urine drug tests, according to an investigation from NBC affiliate KUSA.

Advertisement

Here are six things to know.

1. Last year, Colorado Medicaid paid more than $16 million for urine tests, according to KUSA’s analysis of data from the Colorado Department of Health Care Policy and Financing.

2. In December 2014, the state’s Medicaid program spent $54,857 to cover patients’ urine drug tests, compared to $1.4 million spent in December 2016.

3. The average number of urine tests conducted per patient also increased from 1.45 in December 2014 to 8.48 for the same month two years later, according to the report.

4. When KUSA asked the Colorado Department of Health Care Policy and Financing about their heightened urine test expenditures, CMO Judy Zerzan, MD, told the news agency: “We had looked into this a couple of years ago when other states were having this problem, but we hadn’t refreshed it until you brought it to our attention.”

5. Some lawmakers and health experts believe the increasing price and amount of urine tests represent laboratories attempt to boost profits, according to the report.

“There’s just no other way to explain the numbers when it comes to urine drug testing,” California attorney Harry Nelson, an expert on value of urine screening, told KUSA.

6. KUSA said drug labs justified the urine tests as a crucial tool to identify individuals with addiction issues and fight the national opioid epidemic.

More articles on supply chain:

Sanofi pledges to keep price hikes below healthcare inflation rate: 4 things to know
Abbott employee inspects heart implant used in daughter’s lifesaving surgery
Health, science leaders talk biomedicine at White House meeting: 4 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.